NO974494L - Radiomerkede peptider for diagnostikk og terapi - Google Patents

Radiomerkede peptider for diagnostikk og terapi

Info

Publication number
NO974494L
NO974494L NO974494A NO974494A NO974494L NO 974494 L NO974494 L NO 974494L NO 974494 A NO974494 A NO 974494A NO 974494 A NO974494 A NO 974494A NO 974494 L NO974494 L NO 974494L
Authority
NO
Norway
Prior art keywords
diagnostics
therapy
radiolabeled peptides
radiolabeled
peptides
Prior art date
Application number
NO974494A
Other languages
English (en)
Other versions
NO974494D0 (no
Inventor
Richard T Dean
Daniel A Pearson
John Lister-James
Edgar R Civitello
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diatide Inc filed Critical Diatide Inc
Publication of NO974494D0 publication Critical patent/NO974494D0/no
Publication of NO974494L publication Critical patent/NO974494L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO974494A 1995-03-31 1997-09-29 Radiomerkede peptider for diagnostikk og terapi NO974494L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/414,424 US5849261A (en) 1991-02-08 1995-03-31 Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
PCT/US1996/004308 WO1996030055A2 (en) 1995-03-31 1996-03-29 Radiolabeled peptides for diagnosis and therapy

Publications (2)

Publication Number Publication Date
NO974494D0 NO974494D0 (no) 1997-09-29
NO974494L true NO974494L (no) 1997-11-21

Family

ID=23641398

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974494A NO974494L (no) 1995-03-31 1997-09-29 Radiomerkede peptider for diagnostikk og terapi

Country Status (19)

Country Link
US (2) US5849261A (no)
EP (1) EP0820313A2 (no)
JP (1) JPH11503420A (no)
KR (1) KR19980703459A (no)
CN (1) CN1087631C (no)
AR (1) AR002980A1 (no)
AU (1) AU710923B2 (no)
BR (1) BR9607933A (no)
CA (1) CA2216851C (no)
HU (1) HUP9801390A3 (no)
IL (1) IL117725A (no)
MX (1) MX9707426A (no)
NO (1) NO974494L (no)
NZ (1) NZ306677A (no)
PL (1) PL192734B1 (no)
RU (1) RU2171117C2 (no)
TW (1) TW449482B (no)
WO (1) WO1996030055A2 (no)
ZA (1) ZA962527B (no)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
JP3647881B2 (ja) * 1996-07-12 2005-05-18 イムノメディクス，インコーポレイテッド 放射性金属元素結合ペプチドの類似化合物
US6083480A (en) * 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
US6395255B1 (en) * 1998-06-15 2002-05-28 Thomas Jefferson University Radiolabeled vasoactive intestinal peptide analogs for imaging and therapy
US6409987B1 (en) 1999-04-07 2002-06-25 Intimax Corporation Targeted agents useful for diagnostic and therapeutic applications
DE19917713A1 (de) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik
US6630570B1 (en) 1999-04-09 2003-10-07 Insitut für Diagnostikforschung GmbH Short-chain peptide-dye conjugates as contrast media for optical diagnosis
US7175953B2 (en) * 1999-04-09 2007-02-13 Institute Fuer Diagnostik Forschung Short-warp peptide-dye conjugate as contrast agent for optical diagnostic
US6323313B1 (en) 1999-06-01 2001-11-27 The University Of Washington Annexin derivative with endogenous chelation sites
TWI290146B (en) * 1999-07-29 2007-11-21 Dyax Corp Binding moieties for fibrin
EP1416971A4 (en) * 1999-08-16 2004-05-12 Uab Research Foundation GENE TRANSFER IMAGING AND USES THEREOF
US6358491B1 (en) * 1999-08-27 2002-03-19 Berlex Laboratories, Inc. Somatostatin analogs
US6489297B1 (en) * 2000-02-18 2002-12-03 Dabur Research Foundation Vasoactive intestinal peptide analogs
AU2000263935A1 (en) * 2000-02-18 2001-08-27 Dabur Research Foundation Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
KR100430061B1 (ko) * 2000-03-21 2004-05-03 재단법인 아산사회복지재단 글루코스 유도체에 방사성 동위원소가 표지된 착화합물 및이를 생산하기 위한 조성물이 포함된 키트
US6828304B1 (en) 2000-07-31 2004-12-07 Dabur Research Foundation Peptides for treatment of cancer
KR20020023636A (ko) * 2000-09-23 2002-03-29 송영욱 신규한 방사성 레늄 주석 화합물
US6902718B2 (en) * 2000-10-24 2005-06-07 Diatide, Inc. Stabilization of radiopharmaceutical compositions using hydrophilic thioethers
US6984373B2 (en) * 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
GB0105224D0 (en) * 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
RU2004115104A (ru) * 2001-10-19 2005-02-20 Томас Джефферсон Юниверсити (Us) Расар-композиции и способы визуализации злокачественных опухолей, а также их терапия
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US20050100963A1 (en) 2002-03-01 2005-05-12 Dyax Corporation KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
CA2666005C (en) 2002-03-01 2016-01-19 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
WO2003096024A1 (en) * 2002-05-08 2003-11-20 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with vasoactive intestinal peptide receptor 2 (vpac2)
EP1542709A2 (en) * 2002-08-06 2005-06-22 EPIX Pharmaceuticals, Inc. Peptide aggregates
PL1944312T3 (pl) 2003-03-03 2012-12-31 Dyax Corp Peptydy, które specyficznie wiążą receptor HGF (CMET) i ich zastosowanie
CN100341582C (zh) * 2005-01-07 2007-10-10 北京肿瘤医院 一种含sn3类配体的血管活性肠肽衍生物药物及其制备方法
EP1700608A1 (en) 2005-03-10 2006-09-13 Schering AG Chelators for radioactively labeled conjugates comprising a stabilizing sidechain
CN101089020B (zh) * 2006-06-13 2011-04-20 中国科学院上海应用物理研究所 血管活性肠肽类似物及其放射性标记物，以及它们的制备方法
US20080160557A1 (en) * 2006-09-28 2008-07-03 Cady Roger K Diagnostic Test for Head and Facial Pain
US20100016364A1 (en) * 2006-09-28 2010-01-21 Cady Roger K Method of predictive determination of responsiveness to pharmacological intervention
US20080121535A1 (en) * 2006-09-28 2008-05-29 Cady Roger K Biometric Testing and Monitoring Method and Device
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
WO2008076870A2 (en) * 2006-12-14 2008-06-26 Cady Roger K Method and system for interactive cognitive testing
PT2106808T (pt) * 2006-12-21 2018-03-26 Nihon Mediphysics Co Ltd Agente de imagiologia de diagnóstico radioativo compreendendo ácido 1-amino-3-[18f]fluoro-ciclobutanocarboxílico
EP2147684A1 (en) 2008-07-22 2010-01-27 Bracco Imaging S.p.A Diagnostic Agents Selective Against Metalloproteases
CN102356087A (zh) 2009-03-19 2012-02-15 惠氏有限责任公司 [2-(8,9-二氧代-2,6-二氮杂双环[5.2.0]壬-1(7)-烯-2-基)乙基]膦酸及其前体的制备方法
WO2010121133A2 (en) 2009-04-17 2010-10-21 The General Hospital Corporation Multimodal imaging of fibrin
US9782454B2 (en) * 2010-04-22 2017-10-10 Longevity Biotech, Inc. Highly active polypeptides and methods of making and using the same
EP2968469A4 (en) 2013-03-15 2016-08-31 Longevity Biotech Inc PEPTIDES COMPRISING NON-ENDOGENIC AMINO ACIDS AND METHODS OF MAKING AND USING SAME
US20150344523A1 (en) 2014-05-05 2015-12-03 California Institute Of Technology Mutant akt-specific capture agents, compositions, and methods of using and making
CN108290927B (zh) 2015-07-15 2022-06-24 加州理工学院 Il-17f-特异性捕获剂、组合物以及使用和制造的方法
KR20180118658A (ko) * 2016-03-01 2018-10-31 고쿠리츠 다이가쿠 호우징 지바 다이가쿠 방사성 표지 약제
EP3440101B1 (en) 2016-04-04 2021-10-06 Indi Molecular, Inc. Cd8-specific capture agents, compositions, and methods of using and making
SG10202012408UA (en) * 2016-06-13 2021-01-28 Univ Kagoshima SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IgG-BINDING PEPTIDE
WO2018064597A1 (en) 2016-09-29 2018-04-05 Indi Molecular, Inc. Compositions for detection, inhibition and imaging of indoleamine 2,3-dioxygenase 1 (ido1) and methods of making and using same
US10881879B2 (en) 2017-01-24 2021-01-05 Shenzhen Our New Medical Technologies Development Co., Ltd. Positioning stud for radioactive therapy and stereotactic device
EP3638687A1 (en) 2017-06-15 2020-04-22 Indi Molecular, Inc. Il-17f and il-17a-specific capture agents, compositions, and methods of using and making
US11638764B2 (en) 2018-11-08 2023-05-02 Indi Molecular, Inc. Theranostic capture agents, compositions, and methods of using and making
US20200291391A1 (en) 2019-03-12 2020-09-17 Indi Molecular, Inc. Cross-linked epitopes and methods of use thereof
US20200371101A1 (en) 2019-05-20 2020-11-26 Indi Molecular, Inc. Compositions and methods relating to detection, inhibition, and imaging of indoleamine 2,3-dioxygenase 1 (ido1)
US11414460B2 (en) 2019-07-19 2022-08-16 Institute For Systems Biology KRAS-specific capture agents, compositions, and methods of making and using
WO2022098743A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, imaging, and therapeutic methods targeting folate receptor 1 (folr1)
WO2022098745A1 (en) 2020-11-03 2022-05-12 Indi Molecular, Inc. Compositions, delivery systems, and methods useful in tumor therapy

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444690A (en) * 1982-02-25 1984-04-24 University Patents, Inc. Technetium chelates
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4668503A (en) * 1982-07-26 1987-05-26 Trustees Of University Of Massachusetts Process for labeling amines with 99m Tc
US4571430A (en) * 1982-11-08 1986-02-18 Medi-Physics, Inc. Homocysteine and homocysteinamide derivatives
US4434151A (en) * 1982-11-08 1984-02-28 Medi-Physics, Inc. Bifunctional chelating agents
US4575556A (en) * 1982-11-08 1986-03-11 Medi-Physics, Inc. Bifunctional chelating agents
US4673562A (en) * 1983-08-19 1987-06-16 The Children's Medical Center Corporation Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents
US4493523A (en) * 1983-10-18 1985-01-15 Challenger Circle F, Inc. Adaptive strain relief for wiring devices
DE3577274D1 (de) * 1984-01-23 1990-05-31 Inst Energiteknik Zusammensetzung zur technetium-99m-markierung von proteinhaltigem material.
DE3680924D1 (de) * 1985-01-14 1991-09-26 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
GB8525974D0 (en) * 1985-10-22 1985-11-27 Nyegaard & Co As Chemical substance
JPS62155994A (ja) * 1985-12-27 1987-07-10 Mitsubishi Monsanto Chem Co 活性汚泥のバルキング防止剤及びそのバルキング防止方法
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
DE3728599A1 (de) * 1986-12-10 1988-06-23 Hoechst Ag Verfahren zur herstellung einer mit technetium-99m-markierten organspezifischen substanz
US4939224A (en) * 1987-02-26 1990-07-03 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
US5091514A (en) * 1987-03-26 1992-02-25 Neorx Corporation Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
US4965392A (en) * 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
JPH02504387A (ja) * 1987-04-02 1990-12-13 セントカー・カーデイオバスキユラー・イメージング・パートナーズ・エルピー 金属イオンで抗体を標識付けする方法
WO1989000051A1 (en) * 1987-07-07 1989-01-12 Cytrx Biopool Ltd. Fibrin-binding compound and method
AU635204B2 (en) * 1988-02-09 1993-03-18 Mallinckrodt, Inc. Novel compounds and methods of preparing a metal-radionuclide-labelled protein
US5061641A (en) * 1988-04-01 1991-10-29 Immunomedics, Inc. Method for radiolabeling proteins
JPH03505094A (ja) * 1988-05-02 1991-11-07 ニュー　イングランド　ディーコネス　ホスピタル　コーポレイション 動脈映像のための合成ペプチド
US5218128A (en) * 1988-06-15 1993-06-08 Centocor, Inc. Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
US5180816A (en) * 1988-08-24 1993-01-19 Centocor One vial method for labeling protein/linker conjugates with technetium-99M
US4925650A (en) * 1988-11-16 1990-05-15 Mallinckrodt, Inc. Technetium -99m complex for examining the renal function
WO1990006323A2 (en) * 1988-11-29 1990-06-14 Centocor, Inc. Chimeric proteins incorporating a metal binding protein
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5196510A (en) * 1988-12-29 1993-03-23 Cytogen Corporation Molecular recognition units
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
EP0403243B1 (en) * 1989-06-16 1995-11-08 Merck Frosst Canada Inc. Chelate derivatives of atrial natriuretic factor (ANF)
US5248764A (en) * 1989-06-16 1993-09-28 Merck Frosst Canada, Inc. Chelate derivatives of atrial natriuretic factor (ANF)
US5234907A (en) * 1989-06-30 1993-08-10 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
ATE120374T1 (de) * 1989-07-20 1995-04-15 Sandoz Ag Markierte polypeptidderivate.
FR2650672A1 (fr) * 1989-08-02 1991-02-08 Medgenix Group Sa Procede de marquage de proteines ou polypeptides au technetium-99m, conjugue obtenu, utilisation a titre d'agent d'imagerie, kit de reconstitution desdits conjugues
US5112953A (en) * 1989-12-29 1992-05-12 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
US5175257A (en) * 1989-12-29 1992-12-29 Neorx Corporation Radiolabeled proteins for diagnostic or therapeutic use
EP0463450B1 (en) * 1990-06-26 1994-02-16 Sanwa Kagaku Kenkyusho Co., Ltd. Vasoactive intestinal polypeptide analogues and use thereof
JP2860157B2 (ja) * 1990-10-31 1999-02-24 日本メジフィジックス株式会社 腎機能測定用の既放射能標識テクネチウムキレート注射剤の製造方法
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US5552525A (en) * 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US5965107A (en) * 1992-03-13 1999-10-12 Diatide, Inc. Technetium-99m labeled peptides for imaging
US5561220A (en) * 1991-02-08 1996-10-01 Diatech, Inc. Technetium-99m labeled peptides for imaging inflammation
KR930703024A (ko) * 1991-02-08 1993-11-29 리챠드 티. 딘 영상용 테크네튬-99m표지폴리펩티드
JPH0692991A (ja) * 1991-02-28 1994-04-05 Daicel Chem Ind Ltd 新規活性ペプチド
US5273963A (en) * 1991-03-29 1993-12-28 The George Washington University Compositions and methods for treating small cell and nonsmall cell lung cancers
AU657770B2 (en) * 1991-06-03 1995-03-23 Mallinckrodt Medical, Inc. Radiolabelled somatostatin derivatives, their preparation and use
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5186613A (en) * 1991-12-20 1993-02-16 American Standard Inc. Reverse phase and high discharge temperature protection in a scroll compressor
CA2127284C (en) * 1992-01-03 2002-02-05 Buck A. Rhodes Protein- and peptide-metal ion pharmaceutical applications
DK0720621T3 (da) * 1992-01-14 2001-08-06 Diatide Inc Radiomærkede somatostation-afledte peptider til billeddannende og terapeutiske anvendelser
DE69330494T2 (de) * 1992-02-05 2002-03-28 Mallinckrodt Inc Radioaktiv markierte somatostatin
WO1993017719A1 (en) * 1992-03-13 1993-09-16 Diatech, Inc. TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING INFLAMMATION
US5326856A (en) * 1992-04-09 1994-07-05 Cytogen Corporation Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
ATE329624T1 (de) * 1992-05-21 2006-07-15 Diatide Inc Technetium-99m markierte peptide zur bilderzeugung von thrombus
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
JPH08502261A (ja) * 1992-10-02 1996-03-12 ダイアテク，インコーポレイテッド 多重多価抗血栓症剤
FR2701953B1 (fr) * 1993-02-22 1995-05-24 Centre Nat Rech Scient Protéine de fusion multi-VIP et procédé de préparation de VIP recombinant.
CA2160120A1 (en) * 1993-04-08 1994-10-27 Richard T. Dean Radiolabeled compounds for thrombus imaging
AU7261994A (en) * 1993-07-19 1995-02-20 Resolution Pharmaceuticals Inc. Hydrazino-type radionuclide chelators having an n3s configuration
US5565424A (en) * 1994-02-07 1996-10-15 Ramot - University Authority For Applied Research And Industrial Development Ltd. Superactive VIP antagonists
US5746996A (en) * 1994-06-03 1998-05-05 Immunomedics, Inc. Thiolation of peptides for radionuclide-based radiodetection and radiotherapy
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting

Also Published As

Publication number Publication date
AU710923B2 (en) 1999-09-30
RU2171117C2 (ru) 2001-07-27
TW449482B (en) 2001-08-11
IL117725A (en) 2001-01-28
HUP9801390A3 (en) 1998-12-28
JPH11503420A (ja) 1999-03-26
PL192734B1 (pl) 2006-12-29
NO974494D0 (no) 1997-09-29
MX9707426A (es) 1998-07-31
KR19980703459A (ko) 1998-11-05
CA2216851C (en) 2003-02-11
ZA962527B (en) 1997-01-21
WO1996030055A2 (en) 1996-10-03
AU5529696A (en) 1996-10-16
EP0820313A2 (en) 1998-01-28
WO1996030055A3 (en) 1996-12-12
BR9607933A (pt) 1998-06-02
CA2216851A1 (en) 1996-10-03
US5849261A (en) 1998-12-15
AR002980A1 (es) 1998-05-27
PL322589A1 (en) 1998-02-02
HUP9801390A2 (hu) 1998-10-28
CN1186443A (zh) 1998-07-01
CN1087631C (zh) 2002-07-17
IL117725A0 (en) 1996-07-23
US6007792A (en) 1999-12-28
NZ306677A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
NO974494L (no) Radiomerkede peptider for diagnostikk og terapi
IS5525A (is) Innúðabúnaður og aðferð
IL113459A (en) Electrophoretic cuff apparatus
NO973836D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
IS1810B (is) Úðablöndur úr peptíðum og próteinum
DE69636841D1 (de) Entwicklungsgerät und Bilderzeugungsapparat
NO964541L (no) Porphacyanin og CNC-utvidete porphyriner
NO990836D0 (no) Antitrombotiske azacykloalkylalkanoylpeptider og pseudopeptider
GB9419021D0 (en) Therapeutic protein
NO971505D0 (no) Trofinin og trofininhjelperproteiner
KR960010685A (ko) 펩티드 및 그 용도
DK0780388T3 (da) 5HT1Dalfa og 5HT2A ligander
GB9519865D0 (en) Protein
NO962385L (no) Terapeutiske amider
GB9622436D0 (en) Protein
KR960033582U (ko) 지압구
EP0815220A4 (en) HUMAN AMIN TRANSPORTER
KR970008153U (ko) 지압구
DE69434900D1 (de) Menschliche chemokin-polypeptide
KR970004277U (ko) 지압구
KR970012148U (ko) 지압구
GB9508618D0 (en) Therapeutic protein
NO960920D0 (no) Fremgangsmåte og komponenter for alternativ tannbörste
NO951324D0 (no) Platespant og profillegeme
NO950577D0 (no) Platespant og profillegeme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application